Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.
Skye Bioscience has raised $50.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.
Skye Bioscience's investors include Ally Bridge Group, 5AM Ventures, H. C. Wainwright & Co., Driehaus Capital Management, TYLT Ventures.
Skye Bioscience is headquartered in San Diego, United States.
Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.
Skye Bioscience is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Skye Bioscience — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/skye-bioscience. Accessed August 17, 2026.
VCBacked. (2024). Skye Bioscience — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/skye-bioscience
{{cite web |title=Skye Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/skye-bioscience |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated